Casein Peptides - BioReagent, Protein (Dry Basis) ≥80%

Cat. No.: C1526974
Disponibile su ordine
QUALITÀ & PUREZZA BioReagent ? BioReagent grade — tested suitable for life-science and molecular-biology use. Use for cell culture, assays, and biochemical work needing biological compatibility. Protein (Dry Basis) ≥80%
Synonyms
Casein Enzymatic Hydrolysis Peptides|Milk Casein Peptides
Storage
Protected from light,Room temperature
Shipped In
Normal
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
5g
C1526974-5g
Su ordinazione · 8–12 settimane
17,27€
25g
C1526974-25g
Su ordinazione · 8–12 settimane
43,30€
100g
C1526974-100g
Su ordinazione · 8–12 settimane
121,40€
500g
C1526974-500g
Su ordinazione · 8–12 settimane
399,07€
Enter a quantity for the sizes you want to add.

Panoramica

Casein accounts for approximately 80% of the total protein in cow’s milk and is one of the important sources of high-quality protein in daily life. This product is manufactured from cow’s milk casein via enzymatic hydrolysis and can be widely used in ordinary foods, health foods, biomedicine and other industries.

Specifiche

Sinonimi
Casein Enzymatic Hydrolysis Peptides | Milk Casein Peptides
Specifiche e purezza
BioReagent, Protein (Dry Basis) ≥80%
Stabilità e conservazione
Store at room temperature long term (36 months). Store in the dark.
Condizioni di conservazione di stoccaggio
Protected from light,Room temperature
Spedito in
Normal
Grado
BioReagent
Product Line
Prodotti biologici

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeDataOggetto
ZJ26F1140655ZJ26F1140655Certificate of AnalysisNov 16, 2026 C1526974
ZJ26F1140658ZJ26F1140658Certificate of AnalysisNov 16, 2026 C1526974
ZJ26F1140657ZJ26F1140657Certificate of AnalysisNov 16, 2026 C1526974
ZJ26F1140656ZJ26F1140656Certificate of AnalysisNov 16, 2026 C1526974
Proprietà chimiche e fisiche
SensibilitàLight-sensitive
Domande frequenti e articoli
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

No manufacturer-validated, item-specific protocols are provided. The following are example literature/general protocols to serve as starting points; optimize for your system.

  • Western blot blocking (example)

    1. Dissolve Casein Peptides to 1–5% (w/v) in TBST (20 mM Tris, 150 mM NaCl, 0.05% Tween-20, pH 7.6).
    2. Incubate membrane 45 min at room temperature with gentle agitation.
    3. Proceed with primary antibody incubation in the same buffer with reduced peptide concentration if needed (e.g., 0.1–1%).
  • ELISA plate blocking (example)

    1. Coat plate with antigen; wash.
    2. Add 200 µL/well of 0.5–1% (w/v) Casein Peptides in PBS or carbonate buffer; incubate 1 h at RT.
    3. Wash 3× with PBST and continue with assay.
  • General protease activity assay (example)

    1. Prepare peptide solution (e.g., 0.5–2 mg/mL) in suitable assay buffer.
    2. Add protease; incubate at 37 °C for 10–60 min.
    3. Quench and quantify released peptides/amino acids using your preferred detection method.
  • Sterile filtration

    • If sterility is required, filter through 0.22 µm PES; pre-wet filter to minimize adsorption.

Item-specific concentrations, performance criteria, and validated applications are Not specified for this item; refer to CoA/Spec Sheet and perform pilot titrations.

Biological Roles
  • Source biology (literature/general)

    • Casein is the predominant phosphoprotein family in mammalian milk (α-, β-, κ-caseins), forming micelles that deliver calcium and phosphate. Enzymatic digestion (e.g., by trypsin, chymosin, pepsin) yields diverse peptides.
  • Functional attributes of casein-derived peptides (literature/general; not product claims)

    • Nutritional role: Supply essential amino acids upon digestion.
    • Binding/transport: Phosphoserine-rich motifs can chelate calcium and other divalent metals; peptides are used to study mineral-binding phenomena.
    • Enzymology: Serve as general substrates for endo-/exopeptidases; used to model proteolysis kinetics.
    • Interfacial behavior: Amphiphilic sequences contribute to emulsification and surface activity, relevant in studies of adsorption and biofouling.
  • Research contexts

    • Protease characterization, metal-binding assays, antioxidant capacity assays, and surface passivation studies.

No biological pathway membership, sequence lists, or activity potencies are specified for this item. Any biological roles cited above are general literature characteristics of casein hydrolysates and should not be interpreted as validated attributes for this specific product. For application-critical parameters (e.g., degree of hydrolysis, phosphorylation content), consult the CoA/Spec Sheet or qualify the lot experimentally.

Buffer Applications

Casein Peptides are commonly used in buffer systems for blocking and surface passivation in immunoassays (literature/general). Item-specific recommended concentrations are Not specified for this item; optimize empirically.

  • Western blot blocking (example, literature/general)

    • Prepare 1–5% (w/v) Casein Peptides in TBS or PBS with 0.05% Tween-20 (TBST/PBST).
    • Incubate membranes 30–60 min at room temperature with gentle agitation.
    • Benefits: Reduces nonspecific hydrophobic and charge-mediated interactions.
  • ELISA blocking (example, literature/general)

    • Use 0.1–1% (w/v) in PBS or carbonate buffer (pH 9.4–9.6) after antigen coating.
    • Incubate 30–60 min; wash with PBST/TBST between steps.
  • Immunofluorescence/ICC (example, literature/general)

    • 0.1–1% (w/v) in PBS with 0.05–0.1% Tween-20; include 1–5% normal serum if needed.
  • Practical notes

    • Filter-sterilize (0.22–0.45 µm) if sterility is required.
    • Excessive concentrations can mask epitopes or increase background; titrate to the minimum effective level.
    • Detergents and salts modulate blocking efficacy; adjust Tween-20 (0.01–0.1%) and NaCl (100–300 mM) as needed.

These are general literature protocols intended as starting points. Validate compatibility with specific antibodies, epitopes, and detection chemistries.

Green Alternatives

Consideration of sustainability and safety for peptide-based blocking agents and media supplements (literature/general):

  • Context

    • Casein Peptides are animal-derived (dairy source). Institutions with sustainability or animal-free policies may prefer plant-based or recombinant alternatives.
  • Alternative options and trade-offs

    • Plant-derived peptones (e.g., soy, wheat, pea): Renewable, animal-component–free; peptide profile differs and may alter assay background or growth performance.
    • Recombinant protein/peptide blockers: Consistent composition and animal-free; typically higher cost.
    • Synthetic polymer blockers (e.g., PVP, PEG-based): Chemically defined and scalable; may not mimic proteinaceous blocking as effectively in all assays.
    • BSA or fish gelatin: Proteinaceous blockers with different source risks; also animal-derived.
  • Comparison highlights (literature/general)

    • Consistency: Recombinant/synthetic > dairy/plant hydrolysates (lot variability).
    • Sustainability: Plant/recombinant > dairy/animal.
    • Cost: Plant/dairy hydrolysates < recombinant/synthetic.
    • Performance in Western/ELISA blocking: Casein peptides and milk protein often provide strong suppression of hydrophobic interactions; polymer blockers excel for nucleic-acid or low-fouling surfaces.

Choice should balance performance needs, regulatory constraints (animal-free requirements), cost, and waste minimization (aqueous buffers, minimal hazardous solvents). Item-specific environmental attributes (e.g., manufacturing footprint, certifications) are Not specified for this item; refer to supplier documentation.

Pharmaceutical Uses
  • Status for this item

    • No pharmacopeial designation or excipient status is provided. For this specific product: Not specified for this item; refer to CoA/Spec Sheet.
  • General context (literature/general)

    • Casein hydrolysates appear in bioprocessing and fermentation media development (e.g., seed trains, microbial fermentation for biologics or metabolites). They may improve growth or productivity in certain systems.
    • As excipients in finished dosage forms, defined grades and regulatory documentation are typically required; casein peptides used for research do not meet such requirements by default.
  • Considerations for translational workflows

    • Source and animal-origin documentation, adventitious agent controls, endotoxin levels, and allergen status are critical for cGMP; these attributes are not specified for this research-grade item.

This product is designated For research use only. It is not intended for diagnostic or therapeutic applications or as a component of finished pharmaceuticals.

Physical Properties
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility (literature/general for casein hydrolysates)
    • Typically readily soluble in water and common biological buffers (e.g., PBS, TBS) across a broad pH range; complete dissolution may benefit from gentle warming (≤37 °C) and stirring.
    • Limited solubility in nonpolar organic solvents; miscible with water–miscible organics (e.g., dilute aqueous MeOH) depends on sequence distribution.
  • pH characteristics (literature/general)
    • Solutions are usually near neutral if prepared in water; final pH depends on hydrolysis method and peptide composition.
  • Isoelectric behavior (literature/general)
    • Broad distribution of isoelectric points; mixture exhibits amphoteric behavior with buffering capacity around multiple pH values due to diverse side chains.
  • Hygroscopicity (literature/general)
    • Peptide powders can be hygroscopic; exposure to ambient humidity may cause clumping and reduced shelf life.
  • Thermal properties: BP/MP not applicable for complex peptide mixtures; decomposition precedes boiling (literature/general).
  • Optical rotation: Not specified for this item; refer to CoA/Spec Sheet.
  • UV absorbance (literature/general)
    • Aromatic-containing peptides absorb at 214 nm (peptide bond) and 280 nm (Trp/Tyr); actual absorbance depends on composition and concentration.

All quantitative values and any batch-specific attributes should be confirmed from the item’s CoA/Spec Sheet.

Quality and Grades
  • Item-specific grade

    • Grade/Purity: BioReagent (as provided). This indicates suitability for common biological and biochemical research workflows (e.g., buffer preparation, blocking solutions, general assays), but it is not equivalent to clinical, GMP, or pharmaceutical grade.
  • What BioReagent grade generally implies (literature/general)

    • Manufactured with attention to biochemistry-oriented purity attributes (bioburden, endotoxin, heavy metals) appropriate for research use. Exact acceptance criteria can vary by supplier and product.
    • UV profile, ash, moisture, peptide size distribution, and residual salts may be controlled within ranges appropriate for research. Specific numeric limits are Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/additives

    • Not specified for this item; refer to CoA/Spec Sheet. If present, stabilizers can affect downstream assays (e.g., detergents may influence surface binding or enzyme activity).
  • Batch-to-batch considerations (literature/general)

    • As a peptide mixture, hydrolysis method and processing conditions influence average chain length, phosphorylation content, and hydrophobicity. For sensitive applications, verify critical attributes (e.g., HPLC profile, peptide distribution, residual lactose) on the CoA and consider qualifying a lot.
  • Documentation

    • For traceability, request CoA/Spec Sheet for peptide size distribution, microbial limits, endotoxin (if relevant), and any performance tests. Values not provided are Not specified for this item; refer to CoA/Spec Sheet.
Reaction and Applications
  • Typical research applications (literature/general)

    • Blocking agent in immunoassays and Western blots: Casein peptide solutions can reduce nonspecific binding on membranes or plates, often as an alternative to BSA or nonfat dry milk.
    • Nutrient supplement for microbial and mammalian-expressed enzyme production: Casein hydrolysates supply peptides and amino acids; used in media optimization and fermentation development.
    • Protease substrate pools: Employed in general protease activity tests where complex peptide mixtures are advantageous (e.g., caseinolytic assays).
    • Adsorption and surface passivation: Peptide mixtures can passivate surfaces to minimize nonspecific adsorption of proteins/biomolecules.
    • Antioxidant/metal-chelation studies: Casein-derived peptides are used to study redox-scavenging and metal-binding capacities (literature/general; not a performance claim for this item).
  • Practical tips (literature/general)

    • For blocking: Typical working concentrations range 0.1–5% (w/v) in PBS or TBS with 0.05% Tween-20, adjusted empirically based on assay background.
    • For media: Start with 0.1–1% (w/v) supplementation; sterile-filter if compatible with downstream use.
    • For protease assays: Prepare defined peptide concentrations; monitor peptide bond hydrolysis at 280 nm or with colorimetric reagents (e.g., Folin–Ciocalteu after TCA precipitation) depending on protocol.
  • Compatibility

    • Avoid high concentrations of detergents, strong oxidants, or extreme pH that may modify peptides and confound experimental readouts.

Application suitability and performance characteristics for this specific item are Not specified; validate empirically for your system.

Reaction Conditions

General conditions for common manipulations with peptide mixtures (literature/general). Item-specific recommendations are Not specified for this item; validate empirically.

  • Dissolution and preparation

    • Add gradually to water or buffer under vigorous stirring; allow 10–30 min for full wetting. Gentle heating (≤37 °C) can accelerate dissolution. Adjust pH to ~7.4 unless protocol dictates otherwise.
  • Bioconjugation examples

    • NHS-ester labeling of amines: pH 7.5–8.5 in phosphate/borate buffer; 10–60 min at room temperature; quench with ethanolamine or Tris. Avoid primary-amine buffers during coupling.
    • EDC/sulfo-NHS carboxyl activation: pH 5.0–6.0 (MES) for activation; couple to amine-bearing surfaces at pH 7–8; typical reaction 15–60 min.
    • Maleimide–thiol coupling (if thiols present): pH 6.5–7.5 in phosphate buffer; 30–120 min at RT.
  • Protease assay setup

    • Incubate defined peptide solutions with enzyme at 25–37 °C; monitor hydrolysis via absorbance at 280 nm, fluorescence if labeled, or colorimetric reagents (e.g., Folin–Ciocalteu after TCA precipitation). Include appropriate blanks and calibration.
  • Blocking in immunoassays

    • 0.1–5% (w/v) in TBST/PBST; 30–60 min at RT with gentle agitation; wash thoroughly before probe/antibody steps.
  • Storage of working solutions

    • Keep on ice during use; aliquot and freeze if long-term storage is required (see Storage tab). Avoid repeated freeze–thaw.

These conditions are general literature guidance and should be optimized for specific systems.

Safety and Handling
  • GHS classification, signal word, pictograms, hazard statements: Not specified for this item; consult the product SDS for authoritative information.

  • General laboratory safety (good practice)

    • PPE: Lab coat, suitable gloves (e.g., nitrile), and safety glasses. Avoid inhalation of dusts/aerosols during weighing or reconstitution.
    • Engineering controls: Handle powders in a fume hood or clean bench to minimize airborne particulates.
    • Hygiene: Wash hands thoroughly after handling; do not eat or drink in the lab. For research use only.
  • Allergen/source considerations (literature/general)

    • Derived from milk casein. While not for consumption, laboratories with severe milk allergy concerns should implement precautions to avoid exposure to dust/aerosols.
  • Incompatibilities and stability (literature/general)

    • Avoid strong oxidizers and strong acids/bases that can further degrade or modify peptides.
    • Protect from light as specified; aromatic residues and phosphorylated peptides can be light/oxidation sensitive.
  • First-aid overview (general)

    • Inhalation: Move to fresh air; seek medical attention if symptoms persist.
    • Skin/eye contact: Rinse with water for several minutes; remove contaminated clothing; obtain medical advice if irritation continues.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical advice.

Always defer to the SDS for definitive hazard, toxicological, and disposal guidance. Dispose of aqueous peptide solutions according to institutional and local regulations.

Solvent Selection

Casein Peptides are best handled as aqueous solutions or suspensions. Selection depends on intended use and peptide hydrophobicity distribution.

  • Polarity and miscibility (literature/general)

    • Primary solvent: Water. Readily compatible with biological buffers (PBS, TBS, carbonate, HEPES). Many casein peptides dissolve fully at neutral pH; mildly alkaline pH (7.5–8.5) can aid dissolution of acidic peptides.
    • Co-solvents: Small percentages of ethanol or methanol can assist solubilization of hydrophobic fractions; avoid high organic content for biological assays.
  • Buffer choices (literature/general)

    • PBS/TBS for blocking and immunoassays.
    • Carbonate-bicarbonate (pH ~9.4) for adsorption-based coating or enhanced solubility.
    • Avoid strong acid/base unless required for specific protocols; extreme pH can cause dephosphorylation or further hydrolysis.
  • Practical guidance

    • Wetting: Sprinkle powder slowly into vortexing water/buffer; allow 10–30 minutes with gentle stirring. Sonication can help disperse aggregates.
    • Filtration: If clarity is needed, filter through 0.22–0.45 µm; assess any loss by adsorption.
  • Comparison (literature/general)

    • Water/buffer: Highest biocompatibility; preserves activity in bioassays.
    • Aqueous ethanol (≤10%): May enhance solubility of hydrophobic peptides but could affect some enzymes/antibodies.

Item-specific solubility and recommended solvents are Not specified for this item; refer to CoA/Spec Sheet.

Storage and Reconstitution
  • Storage conditions (item-specific)

    • Protected from light, Room temperature (as provided in Product Data).
    • Shipped: Normal (ambient) conditions.
  • Stability details

    • Shelf-life, moisture content limits, and stability data: Not specified for this item; refer to CoA/Spec Sheet.
  • Reconstitution (literature/general)

    • Solvent: Use ultrapure water or appropriate buffer (PBS, TBS, HEPES). Start at 1–10 mg/mL stock depending on intended use; final concentration is application-dependent.
    • Method: Add powder gradually to the vortex of stirring solvent; mix 10–30 min. Gentle warming (≤37 °C) may assist dissolution. Adjust pH if needed for full solubility.
    • Clarification: Centrifuge briefly or filter (0.22–0.45 µm) if particulate matter persists.
  • Working solution handling (literature/general)

    • Prepare fresh where possible. For extended storage, aliquot and freeze at −20 °C or −80 °C to avoid repeated freeze–thaw (practice guidance; not a specification for this item). Protect from light during storage and use.
    • Avoid microbial contamination; use sterile technique for cell-based applications.
  • Compatibility cautions (literature/general)

    • Avoid strong oxidizers and extreme pH that can modify peptides. Detergents and salts can influence blocking performance—validate after any formulation changes.

For definitive storage limits and reconstitution specifications, consult the product’s CoA/Spec Sheet and SDS.

Structure and Identity

Casein Peptides are a heterogeneous mixture of short peptides produced by partial hydrolysis of casein (the major milk protein). As a mixture, they do not have a single defined structure.

  • Item-specific identifiers

    • CAS: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Average molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES / InChI / InChIKey: Not applicable to undefined peptide mixtures; Not specified for this item; refer to CoA/Spec Sheet.
  • General structural description (literature/general)

    • Composition: Mixture of oligopeptides (typically dipeptides to small oligopeptides), arising from enzymatic or chemical hydrolysis of α-, β-, and κ-caseins.
    • Functional groups: Repeating peptide backbones (amide bonds), side chains spanning acidic (Glu/Asp), basic (Lys/Arg/His), polar (Ser/Thr, including potential phosphoserine residues in casein-derived sequences), and hydrophobic (Leu/Ile/Val/Phe/Pro) residues.
    • Charge behavior: Net charge depends on pH and sequence; mixture displays broad isoelectric distribution.
    • Possible post-translational features: Casein is frequently phosphorylated (notably on serine). Hydrolysates may contain phosphorylated peptides; exact content is batch/process dependent (literature/general, not specified for this item).
  • 2D structural features (descriptive)

    • Linear peptide chains with amide linkages; side chains project alternately from the backbone. No single ring system dominates, though aromatic residues (Phe/Tyr/Trp; Tyr may be phosphorylated in casein species) can be present in some sequences.

Note: Because this is a complex mixture, definitive structural identifiers must be taken from the item’s CoA/Spec Sheet if provided.

Synthetic Utility

While not a traditional small-molecule building block, Casein Peptides offer utility in bioconjugation, assay development, and as complex substrates (literature/general).

  • Bioconjugation handles

    • Primary amines (N-termini, Lys ε-amines) enable coupling with NHS esters, isothiocyanates, aldehyde (via reductive amination), and carbodiimide-mediated linkages.
    • Carboxylates (Asp/Glu C-termini) allow EDC/sulfo-NHS coupling to amines on surfaces or reporters.
    • Thiols (if Cys-containing peptides present) can react with maleimides or undergo disulfide exchange.
    • Phenolic Tyr residues can participate in diazotization/azo-coupling or enzymatic crosslinking (e.g., HRP-mediated).
  • Assay and materials roles

    • Standard complex substrate for protease panels, enabling global caseinolytic activity measurements.
    • Surface passivation and blocking layers on membranes, plastics, and sensor chips to mitigate nonspecific binding.
    • Calibration/normalization controls in peptide quantitation methods (e.g., OPA, ninhydrin) due to diverse primary amine content.
  • Retrosynthetic/value

    • As a heterogeneous mixture, retrosynthetic planning is not applicable; however, selective fractionation (HPLC, ultrafiltration) can yield subpopulations for targeted studies.

Item-specific reactive group abundance and sequence composition are Not specified; confirm experimentally for your lot.

Target Specificity

This product is not an antibody or affinity reagent; target specificity data (antigen, epitope, clone, isotype, species reactivity) are not applicable.

  • Targeting details for this item: Not applicable / Not specified for this item.

Hai bisogno di aiuto per scegliere la qualità?

La nostra guida alla selezione delle qualità copre purezza, stato dello stabilizzatore e idoneità all'applicazione per tutte le varianti del nostro catalogo.

Visualizza la guida alle qualità BioReagent →

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.